tradingkey.logo

CeriBell Inc

CBLL
View Detailed Chart
20.150USD
+0.810+4.19%
Close 02/06, 16:00ETQuotes delayed by 15 min
746.53MMarket Cap
LossP/E TTM

CeriBell Inc

20.150
+0.810+4.19%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.19%

5 Days

-2.23%

1 Month

-7.27%

6 Months

+57.67%

Year to Date

-8.12%

1 Year

-10.88%

View Detailed Chart

TradingKey Stock Score of CeriBell Inc

Currency: USD Updated: 2026-02-06

Key Insights

CeriBell Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 57 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 28.14.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CeriBell Inc's Score

Industry at a Glance

Industry Ranking
57 / 205
Overall Ranking
161 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

CeriBell Inc Highlights

StrengthsRisks
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 152.47% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.44M.
Fairly Valued
The company’s latest PE is -14.32, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 30.92M shares, decreasing 0.09% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 2.34K shares of this stock.

Analyst Rating

Based on 8 analysts
Strong Buy
Current Rating
28.143
Target Price
+45.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

CeriBell Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

CeriBell Inc Info

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Ticker SymbolCBLL
CompanyCeriBell Inc
CEOChao (Xingjuan)
Websitehttps://ceribell.com/
KeyAI